Orbit International Corp. Reports 2026 Third Quarter Results

Orbit International narrows losses, grows backlog, but faces persistent contract and cash flow challenges.

What the company is saying

Orbit International Corp. presents its third quarter and nine-month 2026 results with a focus on modest sales growth, improved gross margins, and a reduced net loss compared to 2025. The company attributes lingering operating losses to contract delays and supply chain disruptions, particularly at the Orbit Instrument division, while highlighting improved performance at Orbit Power Group and tighter cost controls at Simulator Product Solutions (SPS). Executives, including CEO Mitchell Binder and CFO David Goldman, emphasize the impact of delayed government and prime contractor awards, but point to a record backlog of $14.9 million and strong year-to-date bookings at OPG and SPS as evidence of future potential. The narrative is measured, acknowledging both the negative effects of cost overruns and legal fees at SPS and the positive impact of a $1.4 million delayed shipment that finally boosted OPG results. Management stresses recent liquidity actions—a $4.075 million equity raise and a new $6 million line of credit—to strengthen the balance sheet, while also noting the company’s $9.0 million in federal and $0.7 million in state net operating loss carryforwards as a future tax asset. The tone is factual, with forward-looking statements about expected contract awards in 2027 and optimism for improved delivery schedules in the current quarter.

What the data suggests

Net sales rose to $6,159,000 in Q3 2026 from $5,785,000 in Q3 2025, and to $16,291,000 for the nine months ended September 30, 2026, up from $15,724,000 in the prior year. Gross margin for the nine months improved to 26.3% from 24.4%, though Q3 margin declined to 28.7% from 31.9%. The net loss narrowed to $761,000 ($0.20 per share) in Q3 and $4,027,000 ($1.14 per share) for the nine months, both better than 2025’s losses. EBITDA, as adjusted, was a loss of $627,000 in Q3 and $3,158,000 for the nine months, showing only modest improvement. Backlog increased sharply to $14.9 million at September 30, 2026, from $12.3 million at year-end 2025, with OPG bookings up 42.9% and SPS bookings up 6.4% year-over-year. Cash and equivalents were $912,000, with $2,576,000 drawn on the line of credit, and book value per share fell to $2.58 from $3.83 at the start of the year. The company’s liquidity was bolstered by a $4,075,000 equity raise and a new $6 million credit facility, but ongoing operating losses and rising SG&A expenses ($8,003,000 for nine months, up $130,000) underscore persistent cost pressures. Management’s explanations for results—contract delays, supply chain issues, and higher legal and stock compensation costs—are consistent with the numbers. The company’s forward-looking optimism is grounded in a growing backlog and proposal pipeline, but near-term profitability remains elusive.

Analysis

The announcement is factual and balanced, with the majority of claims supported by realised financial and operational data, including net sales, gross margin, net loss, EBITDA, backlog, and liquidity. While there are some forward-looking statements regarding expected contract awards and future production (notably for the Orbit Instrument division and Q-Vio), these are clearly identified as contingent on future events and are not overstated. The company discloses a significant capital raise ($4.075M equity placement) and a new $6M line of credit, but these are paired with ongoing operating losses and only long-term, uncertain benefits (e.g., contract awards not expected until 2027). The tone is measured, and there is no evidence of narrative inflation or exaggerated claims. The gap between narrative and evidence is minimal; the company acknowledges both improvements and ongoing challenges. The only mild inflation is in the optimistic framing of future bookings and awards, but these are not presented as certainties.

Risk flags

• ●Contract delays, especially from government and prime contractor customers, have directly suppressed revenue and operating performance, particularly at the historically profitable Orbit Instrument division. The company reports that $6 million in outstanding proposals are now expected to be awarded only in the first half of 2027, extending the timeline for revenue realization and increasing exposure to further delays.
• ●Liquidity remains tight, with just $912,000 in cash and $2,576,000 drawn on the line of credit as of September 30, 2026, despite a recent $4,075,000 equity raise and a new $6 million credit facility. Ongoing operating losses and rising SG&A expenses continue to pressure cash flow, raising the risk of further dilution or debt if profitability does not materialize.
• ●Segment performance is uneven: while OPG and SPS show improved bookings and margins, the Orbit Instrument division continues to post significant operating losses due to delivery gaps and contract pauses. This division has historically provided strong operating leverage, so its underperformance poses a structural risk to overall results.
• ●Cost overruns and higher-than-expected legal and compliance expenses at SPS following its acquisition have eroded margins and delayed the path to profitability for this subsidiary. The company has trimmed costs, but further increases in SG&A or legal expenses could offset gains from improved sales.
• ●The company’s forward-looking statements about improved delivery schedules and future contract awards are contingent on external factors, notably U.S. government funding and customer procurement cycles, which have already proven unpredictable. The timing and certainty of these awards remain outside management’s control.

Bottom line

Orbit International’s latest results show incremental sales growth, improved gross margins, and a reduced net loss, but the company remains unprofitable and reliant on external financing to support operations. A record $14.9 million backlog and strong bookings growth at OPG and SPS suggest future revenue potential, yet contract delays—especially in the Orbit Instrument division—have pushed meaningful revenue realization into 2027 or later. Liquidity is fragile, with low cash balances and ongoing operating losses despite recent capital raises. Management’s explanations for performance are credible and supported by the numbers, but the path to profitability depends on timely contract awards and sustained execution across all divisions. Investors should watch for evidence of improved delivery schedules in Q4 2026 and confirmation of major contract wins in 2027. The most important takeaway: backlog growth and new financing provide some breathing room, but sustained losses and execution risk mean the turnaround is far from assured.

Announcement summary

(OTC:ORBT) Orbit International Corp. reported net sales of $6,159,000 for the third quarter of 2026, compared to $5,785,000 in the third quarter of 2025. Gross margin for the third quarter was 28.7%, down from 31.9% in the prior year period. The company recorded a net loss of $761,000 ($0.20 loss per share) for the third quarter, compared to a net loss of $875,000 ($0.26 loss per share) in the third quarter of 2025. EBITDA, as adjusted, was a loss of $627,000 ($0.16 loss per share) for the third quarter, compared to a loss of $508,000 ($0.15 loss per share) in the prior year period. For the nine months ended September 30, 2026, net sales were $16,291,000, up from $15,724,000 in the same period of 2025. Gross margin for the nine months was 26.3%, compared to 24.4% in the prior year. Net loss for the nine months was $4,027,000 ($1.14 loss per share), compared to $4,317,000 ($1.30 loss per share) in the prior year. EBITDA, as adjusted, for the nine months was a loss of $3,158,000 ($0.90 loss per share), compared to a loss of $3,506,000 ($1.05 loss per share) in the prior year. Backlog at September 30, 2026 was $14.9 million, compared to $13.1 million at June 30, 2026 and $12.3 million at December 31, 2025. The company attributed lower than anticipated bookings in the second half of 2025 to lower delivery schedules, which adversely affected revenue and operating performance for the first nine months of 2026, particularly at the Orbit Instrument division. A supply chain issue delayed a $1,400,000 Orbit Power Group (OPG) shipment from the second half of 2025 to the first quarter of 2026, which, combined with year-to-date firm bookings, increased OPG revenues and improved operating margins. Orbit Electronics Group (OEG), excluding Simulator Product Solutions LLC (SPS), experienced significantly lower sales, and the Orbit Instrument division had a significant operating loss due to gaps in delivery schedules from customer delays in awarding follow-on sole source contracts. SPS operating results for the nine months were adversely impacted by lower than expected sales, particularly in the first quarter, due to reduced bookings in the second half of 2025 caused by contract delays that were eventually awarded in 2026. SPS revenue in the third quarter was lower than expected due to supply chain issues delaying shipments until the fourth quarter, but operating results improved from the prior comparable period as gross margins increased and costs were tightly controlled. Selling, general and administrative expenses for the nine months ended September 30, 2026 were $8,003,000, compared to $7,873,000 in the prior year, an increase of $130,000, primarily due to higher corporate costs, legal fees, non-cash stock compensation, and higher expenses at SPS. Backlog at September 30, 2026 was approximately $14,850,000, up from $12,300,000 at December 31, 2025, an increase of approximately 20.7%. Orbit Instrument division backlog increased 27.5% from December 31, 2025, SPS backlog increased by 40.7%, and OPG backlog also slightly increased. At September 30, 2026, cash and cash equivalents were approximately $912,000 and borrowings under the Line of Credit (LOC) were $2,576,000. The company closed on a new LOC with an asset-based lender and completed a $4,075,000 equity private placement, issuing 1,630,000 shares at $2.50 per share. The new LOC provides for up to $6,000,000 in financing subject to borrowing base availability. Book value per share at September 30, 2026 was $2.58, compared to $2.85 at June 30, 2026 and $3.83 at December 31, 2025. The company has approximately $9.0 million in available federal and $0.7 million in New York State net operating loss carryforwards. Outstanding proposals from the Orbit Instrument division from two of its largest customers total approximately $6,000,000, with awards now expected during the first half of 2027. Bookings at OPG through October 31, 2026 increased by 42.9% over the comparable year period, and bookings for power supplies utilizing VPX technology exceeded $5,000,000 for the first time. SPS bookings through October 31, 2026 are 6.4% higher year-over-year. Q-Vio has quoted prototype orders for the next generation handheld unit to replace the Defense Advanced Receiver (DAGR), but production awards are not expected before the second half of 2027 due to U.S. Government funding issues.

Disagree with this article?